These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 17110811

  • 1. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

  • 2. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM, Annable L, Bélanger MC, Chouinard G.
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [Abstract] [Full Text] [Related]

  • 3. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC, Atbaşoğlu EC, Balaban H.
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [Abstract] [Full Text] [Related]

  • 4. Vulnerability to tardive dyskinesia.
    Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD.
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [Abstract] [Full Text] [Related]

  • 5. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
    Go CL, Rosales RL, Caraos RJ, Fernandez HH.
    Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 7. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA, Haugland G, Craig TJ.
    Am J Psychiatry; 1991 Oct 28; 148(10):1322-8. PubMed ID: 1680296
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr 28; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 9. Clinical and familial correlates of tardive dyskinesia in India and Israel.
    Bhatia T, Sabeeha MR, Shriharsh V, Garg K, Segman RH, Uriel HL, Strous R, Nimgaonkar VL, Bernard L, Deshpande SN.
    J Postgrad Med; 2004 Apr 28; 50(3):167-72; discussion 172. PubMed ID: 15377799
    [Abstract] [Full Text] [Related]

  • 10. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB, Caligiuri MP.
    J Clin Psychiatry; 1996 Apr 28; 57(4):167-73. PubMed ID: 8601552
    [Abstract] [Full Text] [Related]

  • 11. Cigarette smoking is associated with abnormal involuntary movements in the general male population--a study of men born in 1933.
    Nilsson A, Waller L, Rosengren A, Adlerberth A, Wilhelmsen L.
    Biol Psychiatry; 1997 Mar 15; 41(6):717-23. PubMed ID: 9066996
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of tardive dyskinesia.
    Woerner MG, Kane JM, Lieberman JA, Alvir J, Bergmann KJ, Borenstein M, Schooler NR, Mukherjee S, Rotrosen J, Rubinstein M.
    J Clin Psychopharmacol; 1991 Feb 15; 11(1):34-42. PubMed ID: 1674949
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS.
    J Clin Psychiatry; 2000 Feb 15; 61 Suppl 4():10-4. PubMed ID: 10739325
    [Abstract] [Full Text] [Related]

  • 14. "Positive" and "negative" movement disorders in schizophrenia.
    Sandyk R, Kay SR.
    Int J Neurosci; 1992 Oct 15; 66(3-4):143-51. PubMed ID: 1305614
    [Abstract] [Full Text] [Related]

  • 15. Tardive dyskinesia and diabetes mellitus.
    Ganzini L, Casey DE, Hoffman WF, Heintz RT.
    Psychopharmacol Bull; 1992 Oct 15; 28(3):281-6. PubMed ID: 1362276
    [Abstract] [Full Text] [Related]

  • 16. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
    Modestin J, Vogt Wehrli M, Stephan PL, Agarwalla P.
    Pharmacopsychiatry; 2009 Mar 15; 42(2):57-60. PubMed ID: 19308879
    [Abstract] [Full Text] [Related]

  • 17. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug 15; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

  • 18. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R, Kay SR.
    Funct Neurol; 1991 Aug 15; 6(2):151-7. PubMed ID: 1680777
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME, DeWolfe AS, Mosnaim AD.
    Hillside J Clin Psychiatry; 1987 Aug 15; 9(1):3-11. PubMed ID: 2888712
    [Abstract] [Full Text] [Related]

  • 20. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S, Sandmann U, Genz A.
    Pharmacopsychiatry; 2005 Jul 15; 38(4):171-7. PubMed ID: 16025420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.